Whereas Parkinson’s disease is a chronic, progressive neurological disease and is the second most common neurodegenerative disease in the United States; Whereas there is inadequate data on the incidence and prevalence of Parkinson’s disease, but it is estimated to affect nearly 1,000,000 individuals in the United States, with that number expected to more than double by 2040; Whereas Parkinson’s disease is the 14th leading cause of death in the United States according to the Centers for Disease Control and Prevention; Whereas millions of individuals in the United States are caregivers, family members, and friends who are greatly impacted by Parkinson’s disease; Whereas research suggests the cause of Parkinson’s disease is a combination of genetic and environmental factors, but the exact cause in most individuals is still unknown; Whereas there is currently no objective test or biomarker to diagnose Parkinson’s disease; Whereas there is no known cure or drug to slow or halt the progression of Parkinson's disease, and available treatments are limited in their ability to address the medical needs of patients and remain effective over time; Whereas the symptoms of Parkinson’s disease vary from person to person and can include— (1) tremors; (2) slowness of movement and rigidity; (3) gait and balance difficulty; (4) speech and swallowing disturbances; (5) cognitive impairment and dementia; (6) mood disorders; and (7) a variety of other non-motor symptoms; Whereas volunteers, researchers, caregivers, and medical professionals are working to improve the quality of life of individuals living with Parkinson’s disease and their families; and Whereas increased research, education, and community support services are needed to find more effective treatments and to provide access to quality care to those living with Parkinson's disease today: Now, therefore, be it